Korean Medication Algorithm for Bipolar Disorder 2018 : Safety and Tolerability
- Author:
InKi SOHN
1
;
Won Myong BAHK
;
Bo Hyun YOON
;
Duk In JON
;
Jeong Seok SEO
;
Won KIM
;
Jung Goo LEE
;
Young Sup WOO
;
Jong Hyun JEONG
;
Moon Doo KIM
;
Young Eun JUNG
;
Se Hoon SHIM
;
Hoo Rim SONG
;
Kyung Joon MIN
Author Information
1. Department of Psychiatry, Keyo Hospital, Keyo Medical Foundation, Uiwang, Korea.
- Publication Type:Original Article
- Keywords:
Bipolar disorder;
Weight gain;
Non-adherence;
Lamotrigine;
Hyperprolactinemia;
Genetic counselling;
Algorithm
- MeSH:
Advisory Committees;
Aripiprazole;
Bipolar Disorder;
Education;
Exanthema;
Expert Testimony;
Genetic Counseling;
Hope;
Humans;
Hyperprolactinemia;
Weight Gain
- From:
Mood and Emotion
2018;16(3):134-139
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: Treatment for bipolar disorder is often complicated by various clinical situations. We undertook a survey of expert opinions to facilitate clinical decisions in special situations such as weight gain, metabolic syndrome, hyperprolactinemia, genetic counseling, and treatment adherence.METHODS: A written survey that asked treatment strategies related to safety and tolerability, was prepared focused on weight gain, antipsychotic related hyperprolactinemia, lamotrigine related skin rash, treatment non-adherence and genetic counseling. Sixty-one experts of the review committee completed the survey.RESULTS: In the case of weight gain related to medications, experts preferred exercise and education for diet-control. First chosen medications were lamotrigine, aripiprazole and ziprasidone. Recommendations based on expert survey results for treatment of bipolar patients in other special situations are outlined.CONCLUSION: With limitation of expert opinions, authors hope that results of this study provide valuable information to make clinical decisions about treatment of bipolar disorder in complicated situations.
